Concepedia

Geoffrey B. Varty

GB

Statistics

Publications

55

Citations

3.8K

H-Index

38

Active since

1994

Affiliations

University of California San Diego(Current)

Sanofi (United States)

University of Hertfordshire

Merck & Co., Inc., Rahway, NJ, USA (United States)

CNS Research (United States)

Geoffrey B. Varty is an author at University of California San Diego specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Top concepts

Publications per year

1994–2016

55

Publications

55

Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs

Geoffrey B. Varty, Guy A. Higgins, Guy A. Higgins · Psychopharmacology · 1995 · 230 citations

, , +10

Environmental enrichment and isolation rearing in the rat: effects on locomotor behavior and startle response plasticity

Geoffrey B. Varty, Martin P. Paulus, David Braff et al. · Biological Psychiatry · 2000 · 207 citations

, , +14

M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Deficits in Sprague–Dawley and Wistar Rats

Geoffrey B. Varty · Neuropsychopharmacology · 1999 · 203 citations · Full text

, , +13

The Dopamine D<sub>2</sub>, but not D<sub>3</sub>or D<sub>4</sub>, Receptor Subtype is Essential for the Disruption of Prepulse Inhibition Produced by Amphetamine in Mice

Rebecca J. Ralph, Geoffrey B. Varty, Michele A. Kelly et al. · Journal of Neuroscience · 1999 · 173 citations · Full text

, , +21

The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles

Geoffrey B. Varty, Mariagrazia Grilli, A Forlani et al. · Psychopharmacology · 2005 · 166 citations

, , +11

1–5 of 55